• Mashup Score: 1

    The IP Registry is a repository of the validated IP addresses for over 70,000 content licensing organisations worldwide, accessible by publishers and libraries.

    Tweet Tweets with this article
    • Many #Librarians are already using @ip_registry to report IP updates to @NEJM Don’t forget to submit all future updates via https://t.co/Z4CXYSowko #LibraryTwitter #Libraries #LibraryLife #AcademicLibraries #Publishers #Publishing

  • Mashup Score: 1

    The IP Registry is a repository of the validated IP addresses for over 70,000 content licensing organisations worldwide, accessible by publishers and libraries.

    Tweet Tweets with this article
    • We’re now working with @ip_registry. Don’t forget to confirm your IPs at https://t.co/Z4CXYSG7bW to make sure your access to content is set up correctly. #LibraryTwitter #Libraries #LibraryLife #AcademicLibraries #Publishers #Publishing

  • Mashup Score: 0

    The IP Registry is a repository of the validated IP addresses for over 70,000 content licensing organisations worldwide, accessible by publishers and libraries.

    Tweet Tweets with this article
    • We’re implementing https://t.co/Z4CXYSowko API to improve the process of updating the IP addresses used for access authentication. We are working with @ip_registry and asking subscribers to submit all updates via https://t.co/Z4CXYSowko. #AcademicLibraries #Publishers #Publishing

  • Mashup Score: 0
    NEJM Evidence - 4 year(s) ago

    Editor-in-Chief Jeffrey M. Drazen, MD Jeff joined the New England Journal of Medicine (NEJM) as Editor-in-Chief in 2000 and was appointed Editor-in-Chief, NEJM Group, in 2012, serving in both roles until 2019. He is now NEJM Group Editor and Editor-in-Chief of NEJM…

    Tweet Tweets with this article
    • Sign up for access to learn how @NEJMEvidence will challenge health care professionals to engage in a more discerning way with clinical evidence, clinical trial design, and clinical decision-making. https://t.co/YfvO9CE0vg

  • Mashup Score: 0
    MLA '21 vConference - 4 year(s) ago

    Rebecca Ajtai Liason Librarian UT Health Science Center San Antonio Caroline Allen Librarian University of Iowa Healthcare and Clinics Amy…

    Tweet Tweets with this article
    • Join us today! Jeffrey Drazen, MD and the editorial team will discuss why it’s so important for clinicians to evaluate how trial methods and results impact clinical decision-making. #mlanet21 https://t.co/lzsj6hZjQK https://t.co/VbiRT67SHX

  • Mashup Score: 3
    NEJM Evidence - 4 year(s) ago

    NEJM Evidence, a new monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to…

    Tweet Tweets with this article
    • How do we evaluate the evidence generated in trials? Mark your planner to learn about NEJM Evidence, a new clinical research journal launching early 2022 at #mlanet21. https://t.co/ON61gKAYHc https://t.co/HXMvixioSO